FDA skeptical of benefits from experimental ALS drug

  • by

WASHINGTON (AP) — Federal health regulators issued a negative review Monday of a closely watched experimental drug for the debilitating illness known as Lou Gehrig’s disease, after months of lobbying by patient advocates urging approval.

Leave a Reply

Your email address will not be published. Required fields are marked *